SEC Comment Letter 0000000000-24-005830 to Korro Bio, Inc. (KRRO) (CIK 0001703647) (KRRO)
Korro Bio, Inc. (KRRO) (CIK 0001703647)
Date: May 20, 2024 · CIK: 0001703647 · Accession: 0000000000-24-005830
AI Filing Summary & Sentiment
File numbers found in text: 333-279402
Letter
United States securities and exchange commission logo May 20, 2024 Ram Aiyar President and Chief Executive Officer Korro Bio, Inc. One Kendall Square, Building 600-700 Suite 6-401 Cambridge, MA 02139 Re:Korro Bio, Inc. Registration Statement on Form S-1 Filed May 14, 2024 File No. 333-279402 Dear Ram Aiyar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Marianne C. Sarrazin, Esq.
Show Raw Text
United States securities and exchange commission logo
May 20, 2024
Ram Aiyar
President and Chief Executive Officer
Korro Bio, Inc.
One Kendall Square, Building 600-700
Suite 6-401
Cambridge, MA 02139
Re:Korro Bio, Inc.
Registration Statement on Form S-1
Filed May 14, 2024
File No. 333-279402
Dear Ram Aiyar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Marianne C. Sarrazin, Esq.